{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:22:38Z","timestamp":1782602558504,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Complementary Therapies in Medicine"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.ctim.2016.06.009","type":"journal-article","created":{"date-parts":[[2016,7,3]],"date-time":"2016-07-03T00:05:34Z","timestamp":1467504334000},"page":"108-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Successful treatment of c-kit-positive metastatic Adenoid Cystic Carcinoma (ACC) with a combination of curcumin plus imatinib: A case report"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2501-3097","authenticated-orcid":false,"given":"M.","family":"Demiray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Sahinbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Atahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Demiray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Selcuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.T.","family":"Atayoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctim.2016.06.009_bib0005","doi-asserted-by":"crossref","first-page":"18740","DOI":"10.1073\/pnas.0909114106","article-title":"Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck","volume":"106","author":"Persson","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ctim.2016.06.009_bib0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.oraloncology.2005.06.024","article-title":"Prognostic Factors in Head and Neck Adenoid Cystic Carcinoma","volume":"42","year":"2006","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ctim.2016.06.009_bib0015","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1054\/bjps.2001.3636","article-title":"Adenoid cystic carcinoma of the head and neck","volume":"54","author":"Chummun","year":"2001","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.ctim.2016.06.009_bib0020","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.oraloncology.2006.01.001","article-title":"Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies","volume":"42","author":"Dodd","year":"2006","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ctim.2016.06.009_bib0025","article-title":"Adenoid cystic carcinoma: a review of recent advances, molecular targets, and clinical trials","author":"Dillon","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.ctim.2016.06.009_bib0030","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.oraloncology.2011.04.020","article-title":"Salivary gland carcinoma in Denmark 1990\u20132005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA)","volume":"47","author":"Bj\u00f8rndal","year":"2011","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ctim.2016.06.009_bib0035","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1002\/(SICI)1097-0142(19990515)85:10<2255::AID-CNCR22>3.0.CO;2-D","article-title":"Prognostic factors for long term results of the treatment of patients with malignant submandibular gland tumors","volume":"85","author":"Vander Poorten","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ctim.2016.06.009_bib0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1365-2273.1986.tb01928.x","article-title":"Adenoid cystic carcinoma","volume":"11","author":"Stell","year":"1986","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"10.1016\/j.ctim.2016.06.009_bib0045","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S1470-2045(10)70245-X","article-title":"Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review","volume":"12","author":"Laurie","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctim.2016.06.009_bib0050","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3835(00)00387-6","article-title":"Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma","volume":"154","author":"Jeng","year":"2000","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ctim.2016.06.009_bib0055","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/07853890109002093","article-title":"Tyrosine kinase inhibitor imatinib (STI571) as an anticancer agent for solid tumours","volume":"33","author":"Joensuu","year":"2001","journal-title":"Ann Med"},{"issue":"October (5)","key":"10.1016\/j.ctim.2016.06.009_bib0060","first-page":"545","article-title":"C-Kit expression is rate-Limiting for stem cell factor-Mediated disease progression in adenoid cystic carcinoma of the salivary glands","volume":"7","author":"Phuchareon","year":"2014","journal-title":"Transl Oncol"},{"key":"10.1016\/j.ctim.2016.06.009_bib0065","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bcp.2007.08.016","article-title":"Curcumin as \u201cCurecumin\u201d: from kitchen to clinic","volume":"75","author":"Goel","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ctim.2016.06.009_bib0070","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/01635581.2010.509835","article-title":"Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs","volume":"62","author":"Goel","year":"2010","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.ctim.2016.06.009_bib0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.canlet.2008.03.025","article-title":"Curcumin and cancer: an old-age disease with an age-old solution","volume":"267","author":"Anand","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ctim.2016.06.009_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biocel.2015.05.003","article-title":"Curcumin potentiates the anti-leukemia effects of imatinib by downregulation of the AKT\/mTOR pathway and BCR\/ABL gene expression in Ph+ acute lymphoblastic leukemia","volume":"65","author":"Guo","year":"2015","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.ctim.2016.06.009_bib0085","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/aps.2013.180","article-title":"Curcumin derivative C817 inhibits proliferation of imatinib-resistant chronic myeloid leukemia cells with wild-type or mutant Bcr-Abl in vitro","volume":"35","author":"Wu","year":"2014","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.ctim.2016.06.009_bib0090","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1124\/mol.110.066910","article-title":"Curcumin dually inhibits both mammalian target of rapamycin and nuclear factor-\u03baB pathways through a crossed phosphatidylinositol 3-kinase\/Akt\/I\u03baB kinase complex signaling axis in adenoid cystic carcinoma","volume":"79","author":"Sun","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ctim.2016.06.009_bib0095","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/2193-1801-2-56","article-title":"Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management","volume":"2","author":"Henrotin","year":"2013","journal-title":"SpringerPlus"},{"key":"10.1016\/j.ctim.2016.06.009_bib0100","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0959-8049(99)00229-4","article-title":"Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review andEORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group","volume":"35","author":"Young","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ctim.2016.06.009_bib0105","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O'Brien","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctim.2016.06.009_bib0110","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ctim.2016.06.009_bib0115","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1200\/JCO.2003.04.190","article-title":"Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor","volume":"21","author":"Heinrich","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ctim.2016.06.009_bib0120","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/modpathol.2009.95","article-title":"Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland","volume":"22","author":"Vila","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ctim.2016.06.009_bib0125","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/s10495-010-0497-5","article-title":"Activation of PI3K\/Akt\/IKK-alpha\/NF-kappaB signaling pathway is required for the apoptosis-evasion in human salivary adenoid cystic carcinoma: its inhibition by quercetin","volume":"15","author":"Sun","year":"2010","journal-title":"Apoptosis"},{"key":"10.1016\/j.ctim.2016.06.009_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biocel.2015.05.003","article-title":"Curcumin potentiates the anti-leukemia effects of imatinib by downregulation of the AKT\/mTOR pathway and BCR\/ABL gene expression in Ph+ acute lymphoblastic leukemia","volume":"65","author":"Guo","year":"2015","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.ctim.2016.06.009_bib0135","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2184.2009.00588.x","article-title":"NF-kappaB promotes iNOS and VEGF expression in salivary gland adenoid cystic carcinoma cells and enhances endothelial cell motility in vitro","volume":"42","author":"Zhang","year":"2009","journal-title":"Cell Prolif"},{"key":"10.1016\/j.ctim.2016.06.009_bib0140","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/ijc.24593","article-title":"Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model","volume":"125","author":"Kunnumakkara","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ctim.2016.06.009_bib0145","doi-asserted-by":"crossref","first-page":"24995","DOI":"10.1074\/jbc.270.42.24995","article-title":"Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane)","volume":"270","author":"Singh","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ctim.2016.06.009_bib0150","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/01635581.2010.509835","article-title":"Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs","volume":"62","author":"Goel","year":"2010","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.ctim.2016.06.009_bib0155","first-page":"811","article-title":"Evaluation of liposomal curcumin cytochrome p450 metabolism","volume":"30","author":"Mach","year":"2010","journal-title":"Anticancer Res"}],"container-title":["Complementary Therapies in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229916300802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0965229916300802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:06:28Z","timestamp":1760807188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0965229916300802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":31,"alternative-id":["S0965229916300802"],"URL":"https:\/\/doi.org\/10.1016\/j.ctim.2016.06.009","relation":{},"ISSN":["0965-2299"],"issn-type":[{"value":"0965-2299","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment of c-kit-positive metastatic Adenoid Cystic Carcinoma (ACC) with a combination of curcumin plus imatinib: A case report","name":"articletitle","label":"Article Title"},{"value":"Complementary Therapies in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctim.2016.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}